PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 1, 2022Research and Reports in Tropical Medicine81 citationsOpen Access

Diagnosis and Clinical Management of Chagas Disease: An Increasing Challenge in Non-Endemic Areas

View Full Paper
CSCristina SuárezDNDebbie NolderAGAna García-Mingo

Key Points

Key points are not available for this paper at this time.

Abstract

, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with poverty and stigma. A third of the cases evolve into chronic cardiomyopathy and gastrointestinal disease. The infection is transmitted vertically and by blood/organ donation and can reactivate with immunosuppression. Case identification requires awareness and screening programmes targeting the population at risk (women in reproductive age, donors, immunocompromised patients). Treatment with benznidazole or nifurtimox is most effective in the acute phase and prevents progression to chronic phase when given to children. Treating women antenatally reduces but does not eliminate vertical transmission. Treatment is poorly tolerated, contraindicated during pregnancy, and has little effect modifying the disease in the chronic phase. Screening is easily performed with serology. Migration has brought the disease outside of the endemic countries, where the transmission continues vertically and via blood and tissue/organ donations. There are more than 32 million migrants from Latin America living in non-endemic countries. However, the infection is massively underdiagnosed in this setting due to the lack of awareness by patients, health authorities and professionals. Blood and tissue donation screening policies have significantly reduced transmission in endemic countries but are not universally established in the non-endemic setting. Antenatal screening is not commonly done. Other challenges include difficulties accessing and retaining patients in the healthcare system and lack of specific funding for the interventions. Any strategy must be accompanied by education and awareness campaigns directed to patients, professionals and policy makers. The involvement of patients and their communities is central and key for success and must be sought early and actively. This review proposes strategies to address challenges faced by non-endemic countries.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Suárez et al. (2022) studied this question.

synapsesocial.com/papers/6a6b86f6c681b07c24248bbbhttps://doi.org/10.2147/rrtm.s278135
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Epidemiology of and Impact of Insecticide Spraying on Chagas Disease in Communities in the Bolivian Chaco2013 · 131 citations
  2. 2Peripheral nervous system involvement in human and experimental chronic American trypanosomiasis.1995 · 35 citations
  3. 3MATERNAL TRYPANOSOMA CRUZI INFECTION, PREGNANCY OUTCOME, MORBIDITY, AND MORTALITY OF CONGENITALLY INFECTED AND NON-INFECTED NEWBORNS IN BOLIVIA2004 · 269 citations
  4. 4Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction2003 · 238 citations
  5. 5American trypanosomiasis (Chagas' disease) and the role of molecular epidemiology in guiding control strategies2003 · 167 citations